View in EDS HTML Full Text PDF Full Text

Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials.

Saved in:
Bibliographic Details
Title: Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials.
Authors: Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kalliolias GD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Xu CR; Sanofi, Bridgewater, New Jersey, USA., Harel S; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Lai CH; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Zheng W; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kamal MA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Source: Clinical and translational science [Clin Transl Sci] 2022 Feb; Vol. 15 (2), pp. 384-395. Date of Electronic Publication: 2021 Sep 29.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34523807
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kosloski+MP%22">Kosloski MP</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kalliolias+GD%22">Kalliolias GD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Xu+CR%22">Xu CR</searchLink>; Sanofi, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Harel+S%22">Harel S</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lai+CH%22">Lai CH</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+W%22">Zheng W</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Davis+JD%22">Davis JD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kamal+MA%22">Kamal MA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2022 Feb; Vol. 15 (2), pp. 384-395. <i>Date of Electronic Publication: </i>2021 Sep 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34523807
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cts.13157
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 384
    Titles:
      – TitleFull: Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kosloski MP
      – PersonEntity:
          Name:
            NameFull: Kalliolias GD
      – PersonEntity:
          Name:
            NameFull: Xu CR
      – PersonEntity:
          Name:
            NameFull: Harel S
      – PersonEntity:
          Name:
            NameFull: Lai CH
      – PersonEntity:
          Name:
            NameFull: Zheng W
      – PersonEntity:
          Name:
            NameFull: Davis JD
      – PersonEntity:
          Name:
            NameFull: Kamal MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2022 Feb
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1752-8062
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical and translational science
              Type: main
ResultId 1